XTX Topco Ltd Invests $85,000 in SIGA Technologies, Inc. (NASDAQ:SIGA)

XTX Topco Ltd acquired a new stake in SIGA Technologies, Inc. (NASDAQ:SIGA) during the third quarter, according to its most recent 13F filing with the SEC. The fund acquired 12,654 shares of the company’s stock, valued at approximately $85,000.

Other institutional investors have also added to or reduced their stakes in the company. Wellington Management Group LLP purchased a new position in shares of SIGA Technologies in the third quarter worth about $757,000. AltraVue Capital LLC boosted its holdings in SIGA Technologies by 6.6% in the 2nd quarter. AltraVue Capital LLC now owns 2,177,646 shares of the company’s stock worth $16,528,000 after buying an additional 134,450 shares during the period. Hotchkis & Wiley Capital Management LLC grew its stake in SIGA Technologies by 152.6% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 2,048,440 shares of the company’s stock valued at $13,827,000 after buying an additional 1,237,620 shares in the last quarter. Harbor Capital Advisors Inc. bought a new stake in SIGA Technologies during the 3rd quarter valued at $1,098,000. Finally, Foundry Partners LLC purchased a new stake in shares of SIGA Technologies during the third quarter worth $2,801,000. 55.40% of the stock is owned by hedge funds and other institutional investors.

SIGA Technologies Stock Performance

Shares of NASDAQ SIGA opened at $5.91 on Friday. The stock has a fifty day moving average of $6.76 and a 200-day moving average of $7.73. The stock has a market cap of $422.00 million, a PE ratio of 4.93 and a beta of 0.89. SIGA Technologies, Inc. has a fifty-two week low of $4.26 and a fifty-two week high of $12.83.

SIGA Technologies (NASDAQ:SIGA) last posted its earnings results on Thursday, November 7th. The company reported $0.02 earnings per share for the quarter. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%. The business had revenue of $10.01 million during the quarter. On average, sell-side analysts predict that SIGA Technologies, Inc. will post 1.04 EPS for the current year.

SIGA Technologies Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.